Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress
August 23, 2017 12:31 ET
|
Targovax ASA
Oslo, Norway, 23 August 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target treatment-resistant solid...
Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
August 18, 2017 01:01 ET
|
Targovax ASA
The board of directors of Targovax ASA (the "Company"), has on 18 August 2017, in accordance with the authorizations granted by the general meeting 5 April 2017, resolved: to increase the share...
Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August
August 14, 2017 01:01 ET
|
Targovax ASA
Oslo, Norway, 14 August 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its second quarter and first...
Targovax ASA: Final result of the subsequent offering
July 17, 2017 09:25 ET
|
Targovax ASA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER...
Targovax ASA: Preliminary result of the subsequent offering
July 14, 2017 11:25 ET
|
Targovax ASA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER...
Targovax ASA: Last day of the subscription period in the subsequent offering
July 14, 2017 01:17 ET
|
Targovax ASA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
Targovax ASA: Notification of trade by primary insiders
July 07, 2017 05:17 ET
|
Targovax ASA
Reference is made to the stock exchange announcement dated 3 July 2017 in which Targovax ASA (the "Company") announced the commencement of the subscription period of the rights issue by the Company of...
Targovax ASA: Registration of share capital increase following the private placement
July 06, 2017 05:07 ET
|
Targovax ASA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER...
Targovax ASA: Commencement of subscription period for the subsequent offering
July 03, 2017 01:02 ET
|
Targovax ASA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER...
Targovax ASA: Approval and publication of prospectus; the subsequent offering
June 30, 2017 07:43 ET
|
Targovax ASA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER...